Endovascular stroke trials: why we must enroll all eligible patients

Stroke. 2013 Dec;44(12):3591-5. doi: 10.1161/STROKEAHA.113.002522. Epub 2013 Nov 12.

¹ From the Department of Radiology and Clinical Neurosciences, University of Calgary, AB, Canada (M.G., B.K.M., A.D., M.D.H.); Department of Medicine, University of Ottawa, ON, Canada (M.S.); Comprehensive Stroke Center and Department of Neurology, David Geffen School of Medicine at the University of California, Los Angeles (J.L.S.); Department of Neurology, University Hospital Essen, Germany (H.-C.D.); Department of Neurosurgery, Vanderbilt University, Nashville, TN (J.M.); University Hospital of Geneva, Switzerland (V.M.P.); Department of Neurology, UPMC Stroke Institute, Pittsburgh, PA (T.G.J.); Medical College of Wisconsin and Froedtert Hospital, Milwaukee, WI (O.Z.); Department of Neurosurgery, SUNY at Buffalo, NY (E.I.L.); and Departament de Neurociències, Hospital Universitari Germans Trias i Pujol, Barcelona, Spain (A.D.).

No abstract available

Keywords: acute stroke; endovascular stroke treatment; ethics; ran domized controlled trials; trial enrollment.

Publication types